Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 30, 2026 02:00 ET | Source: Draupnir Bio

Draupnir Bio announces transformational publication detailing extracellular targeted protein degradation technology in Cell Chemical Biology

Draupnir’s novel SORTAC platform expands reach of targeted protein degradation to extracellular proteins, demonstrating in vitro and in vivo efficacy against difficult-to-drug targetsStudy further...
July 17, 2024 07:00 ET | Source: Draupnir Bio

Draupnir Bio completes €12 million seed round to progress development of oral small molecule degraders of extracellular proteins

Draupnir Bio completes €12 million seed round to progress development of oral small molecule degraders of extracellular proteins MP Healthcare and EIFO join existing investors, Gilde Healthcare...
September 23, 2021 07:00 ET | Source: Draupnir Bio

Draupnir Bio establishes Scientific Advisory Board of European experts in cholesterol metabolism and cardiovascular disease

Press Release Draupnir Bio establishes Scientific Advisory Board of European experts in cholesterol metabolism and cardiovascular disease Copenhagen, Denmark, 23 September 2021 – Draupnir Bio...
September 23, 2021 02:00 ET | Source: Draupnir Bio

Draupnir Bio establishes Scientific Advisory Board of European experts in cholesterol metabolism and cardiovascular disease

Press Release Draupnir Bio establishes Scientific Advisory Board of European experts in cholesterol metabolism and cardiovascular disease Copenhagen, Denmark, 23 September 2021 – Draupnir Bio...